Shaping A New Era Of Immunotherapy
Traditionally, cancer vaccines have mainly focused on identifying the subtle differences present in the tumor microenvironment and aimed to create a simple building block that can be used as a vaccine entity. However, the actual drug delivery and stability in the body have largely been ignored leading to limited success in the clinic. At Strike we challenge these obstacles using our ADAC technology.
